GLP-1 Manufacturer Coupons Savings

Medically reviewed by Dr. James Park, MD, PhD (Chief Science Officer, Johns Hopkins-trained, 28 published papers

Brand-name GLP-1 medications come with high sticker prices, but GLP-1 coupon savings programs from manufacturers can reduce your costs significantly. Novo Nordisk and Eli Lilly both offer savings cards, copay assistance, and patient assistance programs. Understanding which programs exist and who qualifies helps you access the best possible price.

Key Takeaways: - Novo Nordisk Savings Programs - Eli Lilly Savings Programs - Learn how to maximize your savings - Common Pitfalls to Avoid

These programs change frequently. Eligibility rules shift, discount amounts adjust, and new programs launch. This guide covers what is available as of 2026 and how to take advantage of each option.

Novo Nordisk Savings Programs

Novo Nordisk manufactures semaglutide products and offers several programs to help patients afford their medications.

NovoCare Savings Card is the primary savings program for commercially insured patients. If you have commercial insurance, this card may reduce your out-of-pocket cost. The specific savings amount depends on your plan's coverage and the current program terms. Patients with eligible commercial insurance may pay as little as $0 to $25 per month. Visit the NovoCare website or ask your provider for current terms.

Patient Assistance Program (PAP) helps uninsured patients who meet income requirements. If you don't have insurance coverage for your medication and your income falls within the program's guidelines, you may receive your medication at no cost. Application requires documentation of income and insurance status.

Copay assistance works alongside your existing insurance. After your insurance processes the claim, the savings program covers a portion of your remaining copay. This bridges the gap between what your insurance pays and what you owe.

Important limitations apply. These programs can't be used with Medicare, Medicaid, Tricare, or other government insurance programs. Federal regulations prohibit manufacturer copay assistance for government-insured patients. The programs also have annual maximum benefit amounts, after which you return to your regular cost-sharing.

"The conversation about obesity needs to shift from willpower to biology. These medications work because obesity is a neuroendocrine disease, not a character flaw.") Dr. Fatima Cody Stanford, MD, MPH, Massachusetts General Hospital

Check the current program terms directly with Novo Nordisk since savings amounts and eligibility criteria are subject to change. For alternative affordable access, FormBlends pricing offers transparent compounded medication costs.

Free Download: Cost Comparison Spreadsheet A side-by-side comparison of every manufacturer savings program including eligibility requirements, savings amounts, and application steps. Get yours free (we'll email it to you instantly.

[Download Now]

Eli Lilly Savings Programs

Eli Lilly manufactures tirzepatide products and offers its own set of savings programs.

Lilly Savings Card provides copay savings for commercially insured patients filling prescriptions for tirzepatide. Eligible patients may pay a reduced copay per fill. The program has specific terms regarding maximum monthly savings and annual limits. Check with Lilly directly for current amounts.

Patient Perspective: "My insurance denied Wegovy twice. My provider helped me file a peer-to-peer review appeal with supporting documentation from my labs and BMI history. Third time was approved. Don't give up after the first denial.") Brian C., 45, FormBlends patient (name changed for privacy)

Lilly Patient Assistance Program offers medication at no cost to qualifying uninsured patients. Income limits apply. The application process requires documentation from both the patient and prescribing provider. Processing typically takes 2 to 4 weeks.

Lilly Solutions Center serves as a hub for connecting patients with available programs. Their representatives can help you identify which savings options you qualify for and assist with enrollment. You can reach them by phone or through their website.

The same government insurance exclusions apply. Medicare, Medicaid, and other federal or state government program beneficiaries can't use manufacturer savings cards. This is a federal regulation, not a Lilly-specific policy.

Both Novo Nordisk and Eli Lilly programs require you to have a valid prescription. You can't enroll in savings programs without a current prescription from a licensed provider. If you don't yet have a prescription, talk to a FormBlends provider to get evaluated.

How to Maximize Your Savings

Stacking strategies can reduce your out-of-pocket costs beyond what any single program offers. Here is how to get the most savings.

Step 1^[1]: Start with insurance. File through your insurance first to see what they cover. Even partial coverage reduces your starting out-of-pocket number. Prior authorization may be required but is worth pursuing. Our insurance coverage guide walks you through this process.

Step 2: Apply the manufacturer savings card. After insurance processes your claim, apply the savings card to your remaining copay. The card typically covers some or all of your cost-sharing up to the program maximum.

Step 3: Use pre-tax accounts. If you still have out-of-pocket costs after insurance and savings cards, pay with your HSA or FSA. This saves you an additional 20 to 35 percent by using pre-tax dollars.

Step 4: Explore additional assistance. If you're still struggling with costs, contact the manufacturer's patient assistance program. Non-profit organizations focused on obesity and diabetes may also offer grants or assistance.

Compare against compounded options. Before going through the multi-step process above, compare your estimated out-of-pocket cost against compounded medication pricing. Sometimes a compounded alternative through a provider like FormBlends costs less than your brand-name copay after insurance, especially on high-deductible plans.

The savings card enrollment process is usually simple. Most programs offer online enrollment through the manufacturer's website. You may need your insurance information, prescription details, and provider information. Enrollment is typically free.

Common Pitfalls to Avoid

The savings program market has traps. Knowing about them in advance helps you avoid costly mistakes.

Assuming the savings card covers everything. Savings cards have maximum monthly and annual benefit amounts. Once you hit the maximum, you revert to your normal cost-sharing. Calculate whether the program covers your full annual treatment cost or only a portion.

Forgetting to renew. Most savings cards expire and require annual re-enrollment. Set a reminder to renew before your card expires. Lapsed enrollment means your next fill reverts to full cost-sharing.

Using the card with government insurance. If you have Medicare, Medicaid, or Tricare, manufacturer savings cards aren't available to you. Using them is a violation of federal anti-kickback laws. If your pharmacy accidentally applies one, it could create problems.

Not checking formulary changes. Insurance formularies change annually, usually in January. Your medication may move to a different tier or be removed entirely. Re-check your coverage at the start of each plan year.

Ignoring total cost of treatment. Monthly savings are great, but consider the total cost over your treatment timeline. A program that saves $200 per month but limits total annual benefits to $1,500 only covers about 7 months. Plan accordingly.

For a full cost analysis across all GLP-1 access options, use our savings calculator or read the complete price guide.

Frequently Asked Questions

Can I use a manufacturer savings card if I have Medicare?

No. Federal regulations prohibit the use of manufacturer copay assistance programs with Medicare, Medicaid, Tricare, and other government insurance programs. Medicare patients should explore Medicare Part D coverage, patient assistance programs, or compounded medication alternatives.

How much can I save with a GLP-1 manufacturer savings card?

Savings amounts vary by program and change periodically. Some programs reduce copays to as low as $0 to $25 per month for eligible patients. Others have percentage-based discounts. Check the current program terms directly with Novo Nordisk or Eli Lilly for specific amounts.

Do savings cards work at all pharmacies?

Most manufacturer savings cards work at major retail and mail-order pharmacies. Some programs have preferred pharmacy networks that offer additional savings. Check your card's terms for any pharmacy restrictions.

Can I combine a savings card with an HSA or FSA?

Yes. You can pay your remaining out-of-pocket costs (after insurance and savings card benefits) with HSA or FSA funds. This combination provides the maximum possible savings on your GLP-1 medication.

What happens if my savings card application is denied?

Denial usually means you don't meet the eligibility criteria. Common reasons include government insurance, income above program limits, or medication not matching program-covered products. If denied, consider compounded medication options or reapply if your circumstances change.

Your Personalized Plan Is Waiting

No two patients are the same, and your protocol shouldn't be either. FormBlends providers create customized treatment plans based on your health profile, goals, and preferences.

Get Your Personalized Plan →

Sources &. References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
6. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
7. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2^[6] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
8. Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3^[7] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
9. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4^[8] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
10. Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
11. Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections, United States, 2012. MMWR. 2012;61(41):839-842.
12. U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.

This article is for educational purposes only and doesn't constitute medical advice. Always consult with a licensed healthcare provider before starting, changing, or stopping any medication or supplement. FormBlends connects you with licensed providers who can evaluate your individual health needs.

Last updated: 2026-03-24